Utah Medical Products Inc
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal … Read more
Utah Medical Products Inc (UTMD) - Net Assets
Latest net assets as of December 2025: $119.27 Million USD
Based on the latest financial reports, Utah Medical Products Inc (UTMD) has net assets worth $119.27 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($122.54 Million) and total liabilities ($3.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $119.27 Million |
| % of Total Assets | 97.33% |
| Annual Growth Rate | 8.94% |
| 5-Year Change | 11.32% |
| 10-Year Change | 72.24% |
| Growth Volatility | 28.25 |
Utah Medical Products Inc - Net Assets Trend (1987–2025)
This chart illustrates how Utah Medical Products Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Utah Medical Products Inc (1987–2025)
The table below shows the annual net assets of Utah Medical Products Inc from 1987 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $119.27 Million | +1.57% |
| 2024-12-31 | $117.43 Million | -8.48% |
| 2023-12-31 | $128.31 Million | +12.31% |
| 2022-12-31 | $114.25 Million | +6.64% |
| 2021-12-31 | $107.14 Million | +4.20% |
| 2020-12-31 | $102.82 Million | +1.71% |
| 2019-12-31 | $101.09 Million | +13.60% |
| 2018-12-31 | $88.99 Million | +13.91% |
| 2017-12-31 | $78.12 Million | +12.82% |
| 2016-12-31 | $69.24 Million | -0.58% |
| 2015-12-31 | $69.65 Million | +7.89% |
| 2014-12-31 | $64.56 Million | +6.56% |
| 2013-12-31 | $60.58 Million | +18.85% |
| 2012-12-31 | $50.97 Million | +25.07% |
| 2011-12-31 | $40.76 Million | +7.84% |
| 2010-12-31 | $37.79 Million | -0.50% |
| 2009-12-31 | $37.98 Million | +9.13% |
| 2008-12-31 | $34.80 Million | -10.27% |
| 2007-12-31 | $38.79 Million | +7.40% |
| 2006-12-31 | $36.12 Million | +9.92% |
| 2005-12-31 | $32.86 Million | -9.13% |
| 2004-12-31 | $36.16 Million | -1.03% |
| 2003-12-31 | $36.53 Million | +132.36% |
| 2002-12-31 | $15.72 Million | -13.65% |
| 2001-12-31 | $18.21 Million | +47.46% |
| 2000-12-31 | $12.35 Million | -34.29% |
| 1999-12-31 | $18.79 Million | -27.73% |
| 1998-12-31 | $26.00 Million | +15.04% |
| 1997-12-31 | $22.60 Million | -7.38% |
| 1996-12-31 | $24.40 Million | -16.44% |
| 1995-12-31 | $29.20 Million | +24.79% |
| 1994-12-31 | $23.40 Million | -5.65% |
| 1993-12-31 | $24.80 Million | -0.40% |
| 1992-12-31 | $24.90 Million | +41.48% |
| 1991-12-31 | $17.60 Million | +53.04% |
| 1990-12-31 | $11.50 Million | +64.29% |
| 1989-12-31 | $7.00 Million | +11.11% |
| 1988-12-31 | $6.30 Million | +36.96% |
| 1987-12-31 | $4.60 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Utah Medical Products Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 50000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $119.27 Million | 100.00% |
| Total Equity | $119.27 Million | 100.00% |
Utah Medical Products Inc Competitors by Market Cap
The table below lists competitors of Utah Medical Products Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xiangtan Yongda Mach Mnfg Co
SHE:001239
|
$177.08 Million |
|
Pharmagest Interactive
LSE:0R9T
|
$177.12 Million |
|
OmniAb Inc.
NASDAQ:OABI
|
$177.13 Million |
|
Shandong Huapeng Glass Co Ltd
SHG:603021
|
$177.13 Million |
|
Jack In The Box Inc
NASDAQ:JACK
|
$177.01 Million |
|
Avacta Group Plc
PINK:AVCTF
|
$176.98 Million |
|
Blue Acquisition Corp. Class A Ordinary Shares
NASDAQ:BACC
|
$176.95 Million |
|
OKEA A.S. NK-1
F:3SX
|
$176.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Utah Medical Products Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 117,427,000 to 119,268,000, a change of 1,841,000 (1.6%).
- Net income of 11,286,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 11,908,000.
- Other factors decreased equity by 21,353,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.29 Million | +9.46% |
| Other Comprehensive Income | $11.91 Million | +9.98% |
| Other Changes | $-21.35 Million | -17.9% |
| Total Change | $- | 1.57% |
Book Value vs Market Value Analysis
This analysis compares Utah Medical Products Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.74x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 139.24x to 1.74x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1987-12-31 | $0.46 | $64.05 | x |
| 1988-12-31 | $0.58 | $64.05 | x |
| 1989-12-31 | $0.62 | $64.05 | x |
| 1990-12-31 | $0.99 | $64.05 | x |
| 1991-12-31 | $1.50 | $64.05 | x |
| 1992-12-31 | $2.06 | $64.05 | x |
| 1993-12-31 | $2.13 | $64.05 | x |
| 1994-12-31 | $2.24 | $64.05 | x |
| 1995-12-31 | $2.85 | $64.05 | x |
| 1996-12-31 | $2.58 | $64.05 | x |
| 1997-12-31 | $2.68 | $64.05 | x |
| 1998-12-31 | $3.13 | $64.05 | x |
| 1999-12-31 | $2.61 | $64.05 | x |
| 2000-12-31 | $2.07 | $64.05 | x |
| 2001-12-31 | $3.50 | $64.05 | x |
| 2002-12-31 | $2.98 | $64.05 | x |
| 2003-12-31 | $7.48 | $64.05 | x |
| 2004-12-31 | $7.75 | $64.05 | x |
| 2005-12-31 | $7.84 | $64.05 | x |
| 2006-12-31 | $8.93 | $64.05 | x |
| 2007-12-31 | $9.72 | $64.05 | x |
| 2008-12-31 | $8.97 | $64.05 | x |
| 2009-12-31 | $10.46 | $64.05 | x |
| 2010-12-31 | $10.37 | $64.05 | x |
| 2011-12-31 | $11.18 | $64.05 | x |
| 2012-12-31 | $13.73 | $64.05 | x |
| 2013-12-31 | $16.05 | $64.05 | x |
| 2014-12-31 | $17.11 | $64.05 | x |
| 2015-12-31 | $18.46 | $64.05 | x |
| 2016-12-31 | $18.38 | $64.05 | x |
| 2017-12-31 | $20.91 | $64.05 | x |
| 2018-12-31 | $23.74 | $64.05 | x |
| 2019-12-31 | $27.04 | $64.05 | x |
| 2020-12-31 | $28.00 | $64.05 | x |
| 2021-12-31 | $29.27 | $64.05 | x |
| 2022-12-31 | $31.36 | $64.05 | x |
| 2023-12-31 | $35.28 | $64.05 | x |
| 2024-12-31 | $33.52 | $64.05 | x |
| 2025-12-31 | $36.81 | $64.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Utah Medical Products Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.46%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.30%
- • Asset Turnover: 0.31x
- • Equity Multiplier: 1.03x
- Recent ROE (9.46%) is below the historical average (23.29%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1987 | 8.70% | 5.26% | 1.04x | 1.59x | $-60.00K |
| 1988 | 22.22% | 10.37% | 1.36x | 1.57x | $770.00K |
| 1989 | 37.14% | 14.53% | 1.50x | 1.70x | $1.90 Million |
| 1990 | 37.39% | 17.99% | 1.53x | 1.36x | $3.15 Million |
| 1991 | 30.68% | 18.12% | 1.39x | 1.22x | $3.64 Million |
| 1992 | 27.71% | 19.11% | 1.29x | 1.12x | $4.41 Million |
| 1993 | 28.23% | 18.92% | 1.31x | 1.14x | $4.52 Million |
| 1994 | 30.34% | 17.93% | 1.45x | 1.17x | $4.76 Million |
| 1995 | 28.77% | 20.00% | 1.26x | 1.14x | $5.48 Million |
| 1996 | 36.07% | 22.74% | 1.34x | 1.18x | $6.36 Million |
| 1997 | 19.03% | 17.70% | 0.77x | 1.39x | $2.04 Million |
| 1998 | 18.85% | 17.69% | 0.87x | 1.23x | $2.30 Million |
| 1999 | 29.10% | 18.57% | 1.06x | 1.48x | $3.59 Million |
| 2000 | 43.52% | 19.76% | 1.07x | 2.06x | $4.14 Million |
| 2001 | 32.59% | 22.02% | 1.14x | 1.29x | $4.11 Million |
| 2002 | 45.57% | 26.19% | 1.17x | 1.49x | $5.59 Million |
| 2003 | 56.83% | 76.50% | 0.55x | 1.36x | $17.11 Million |
| 2004 | 28.27% | 38.59% | 0.64x | 1.14x | $6.60 Million |
| 2005 | 22.97% | 27.25% | 0.67x | 1.27x | $4.26 Million |
| 2006 | 22.62% | 28.41% | 0.65x | 1.22x | $4.56 Million |
| 2007 | 20.38% | 27.73% | 0.62x | 1.19x | $4.03 Million |
| 2008 | 20.70% | 25.93% | 0.72x | 1.12x | $3.72 Million |
| 2009 | 16.48% | 24.15% | 0.62x | 1.10x | $2.46 Million |
| 2010 | 15.91% | 23.94% | 0.61x | 1.09x | $2.23 Million |
| 2011 | 18.19% | 19.58% | 0.50x | 1.87x | $3.34 Million |
| 2012 | 19.95% | 24.47% | 0.54x | 1.51x | $5.07 Million |
| 2013 | 18.83% | 28.17% | 0.50x | 1.33x | $5.35 Million |
| 2014 | 17.63% | 27.56% | 0.51x | 1.26x | $4.92 Million |
| 2015 | 17.00% | 29.49% | 0.51x | 1.14x | $4.88 Million |
| 2016 | 17.51% | 30.86% | 0.51x | 1.11x | $5.20 Million |
| 2017 | 10.89% | 20.54% | 0.45x | 1.19x | $692.80K |
| 2018 | 20.85% | 44.18% | 0.42x | 1.12x | $9.65 Million |
| 2019 | 14.57% | 31.40% | 0.43x | 1.09x | $4.62 Million |
| 2020 | 10.50% | 25.60% | 0.38x | 1.09x | $515.80K |
| 2021 | 13.80% | 30.15% | 0.42x | 1.08x | $4.07 Million |
| 2022 | 14.42% | 31.51% | 0.42x | 1.08x | $5.05 Million |
| 2023 | 12.96% | 33.12% | 0.37x | 1.06x | $3.80 Million |
| 2024 | 11.81% | 33.92% | 0.33x | 1.04x | $2.13 Million |
| 2025 | 9.46% | 29.30% | 0.31x | 1.03x | $-640.80K |
Industry Comparison
This section compares Utah Medical Products Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Utah Medical Products Inc (UTMD) | $119.27 Million | 8.70% | 0.03x | $177.03 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |